S. Ogura

发表

A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2001, Cancer research.

Cyclin E expression, a potential prognostic marker for non-small cell lung cancers.

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic Significance of p 27 KIP 1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2000 .

Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy.

Koichi Yamazaki, Shinichi Shimizu, Hiroki Shirato, 2005, International journal of radiation oncology, biology, physics.

Real‐time tumor‐tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy

Koichi Yamazaki, Shinichi Shimizu, Hiroki Shirato, 2002, Cancer.

Detection of lung tumor movement in real-time tumor-tracking radiotherapy.

H Shirato, T Nishioka, K Miyasaka, 2001, International journal of radiation oncology, biology, physics.

Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines

T. Betsuyaku, Y. Kawakami, S. Ogura, 1996, Cancer Chemotherapy and Pharmacology.

Thallium-201 uptake, histopathological differentiation and Na-K ATPase in lung adenocarcinoma.

Y. Kawakami, S. Ogura, K. Itoh, 1996, Journal of Nuclear Medicine.

Cytological characteristics of pulmonary large cell neuroendocrine carcinoma.

T. Hirano, Y. Tagawa, S. Ogura, 2005, Lung cancer.

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

M. Nishimura, H. Dosaka-akita, S. Ogura, 2011, Oncology.

Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung.

Y. Kawakami, S. Ogura, H. Isobe, 1994, Journal of clinical pathology.

Increased expression of β‐catenin predicts better prognosis in nonsmall cell lung carcinomas

M. Nishimura, K. Furuuchi, T. Moriuchi, 2002 .

RCAS1 Expression: A Potential Prognostic Marker for Adenocarcinomas of the Lung

M. Nishimura, H. Dosaka-akita, F. Hommura, 2002, Oncology.

Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.

M. Nishimura, H. Dosaka-akita, S. Ogura, 2003, Human gene therapy.

Tumor angiogenesis in human lung adenocarcinoma

S. Abe, Y. Kawakami, S. Ogura, 1994, Cancer.

Pulmonary drug-metabolizing enzyme in alveolar macrophages in relation to cigarette smoking.

Y. Kawakami, S. Ogura, S. Abe, 1990, Japanese journal of medicine.

Prognostic significance of p27/KIP1 protein (p27) and Ki-67 growth fraction in non-small cell lung cancers (NSCLCs)

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2000 .

Susceptibility to Oxygen Desaturation during Bronchoscopy in Elderly Patients with Pulmonary Fibrosis

M. Nishimura, S. Ogura, K. Yamazaki, 2006, Respiration.

Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas

M. Nishimura, R. Onimaru, H. Shirato, 2002, Cancer.

Quantitative immunocytochemical assays of topoisomerase II in lung adenocarcinoma cell lines. Correlation to topoisomerase II alpha content and topoisomerase II catalytic activity.

Y. Kawakami, S. Ogura, K. Yamazaki, 1996, Acta oncologica.

Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis

K. Inoue, S. Abe, Y. Kawakami, 2004, Virchows Archiv.

Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer

K. Inoue, S. Abe, Y. Kawakami, 1994, Cancer.

Cytological Characteristics of Pulmonary Pleomorphic and Giant Cell Carcinomas

T. Hirano, Y. Matsuno, Y. Tagawa, 2011, Acta Cytologica.

[A necrobiotic nodule indistinguishable from lung adenocarcinoma].

Y. Kawakami, S. Ogura, H. Isobe, 1995, Nihon Kyobu Shikkan Gakkai zasshi.

Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung

H. Dosaka-akita, Y. Kawakami, S. Ogura, 2000, Cancer.

Nucleolar organizer regions in precancerous and cancerous lesions of the bronchus

S. Abe, Y. Kawakami, S. Ogura, 1991, Cancer.

Nucleolar organiser regions as a marker of growth rate in squamous cell carcinoma of the lung.

Y. Kawakami, S. Ogura, H. Kunikane, 1992, Thorax.

Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma

S. Abe, Y. Kawakami, S. Ogura, 1992, Cancer.

ANALYSIS OF NUCLEOLAR ORGANIZER REGIONS IN COLONIC EPITHELIAL NEOPLASMS

S. Ogura, M. Hosokawa, Y. Kawakami, 1993 .

[Nucleolar organizer regions, nuclear DNA content, and proliferative activity in adenocarcinoma of the lung].

Y. Kawakami, S. Ogura, H. Kunikane, 1991, Nihon Kyobu Shikkan Gakkai zasshi.

Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

H. Dosaka-akita, Y. Kawakami, H. Katoh, 1999, British Journal of Cancer.

[Clinical indicators of malignancy of lung cancer].

S. Ogura, H. Isobe, S. Abe, 1994, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

Predictive value of expression of P53, Bcl‐2 and lung resistance‐related protein for response to chemotherapy in non‐small cell lung cancers

M. Nishimura, H. Dosaka-akita, S. Ogura, 2003, Cancer science.

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

M. Nishimura, H. Dosaka-akita, S. Ogura, 2006, British Journal of Cancer.

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

M. Nishimura, M. Munakata, H. Dosaka-akita, 2007, BMC Cancer.

Analysis of the response and toxicity to gefitinib of non-small cell lung cancer.

M. Nishimura, M. Munakata, H. Dosaka-akita, 2005, Anticancer research.

Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.

M. Nishimura, M. Munakata, H. Dosaka-akita, 2006, Anticancer research.

Tumor angiogenesis in human lung adenocarcinoma

S. Abe, Y. Kawakami, S. Ogura, 1994, Cancer.

Mucous gland adenoma of the trachea resected with an endoscopic neodymium: yttrium aluminum garnet laser.

Y. Kawakami, S. Ogura, K. Yamazaki, 1996, Internal medicine.

Myocardial metastasis from primary lung cancer: myocardial infarction-like ECG changes and pathologic findings.

M. Munakata, Y. Kawakami, S. Ogura, 1991, Japanese journal of medicine.

Inductively coupled plasma mass spectrometry for the determination of platinum accumulation in human non-small cell lung cancer cell lines

Y. Kawakami, S. Ogura, H. Isobe, 1998, International Journal of Clinical Oncology.

Intracellular accumulation of thallium as a marker of cisplatin cytotoxicity in nonsmall cell lung carcinoma

Y. Kawakami, Takeshi Saito, S. Ogura, 1998, Cancer.

Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.

Y. Kawakami, S. Ogura, T. Ishida, 1998, British Journal of Cancer.

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers

Koichi Yamazaki, Satoshi Oizumi, Masaharu Nishimura, 2003, Cancer science.

Inverted Papilloma of the Nasal Cavity Presenting with Massive Amounts of Squamous Metaplastic Cells in Sputum

M. Nishimura, Y. Furuta, H. Dosaka-akita, 2002, Acta Cytologica.

Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung.

Y. Kawakami, S. Ogura, K. Itoh, 1994, British Journal of Cancer.

Examination of Therapeutic Sensitivity for Malignant Pleural and Pericardial Effusion: Confocal Laser Scanning Microscopic Studies on the Intracellular Distribution of Anthracyclines.

Y. Kawakami, S. Ogura, H. Isobe, 1994 .

A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405.

S. Ogura, T. Harada, S. Oizumi, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.

Satoshi Konno, Tomoko Betsuyaku, Yoichi M Ito, 2012, American journal of respiratory and critical care medicine.

A Rare Case of Bronchial Glomus Tumor

H. Dosaka-akita, Y. Kawakami, H. Katoh, 2001, Respiration.

[The outline of the general rule for clinical and pathological record of lung cancer].

Y. Kawakami, S. Ogura, Y. Kawakami, 2000, Nihon rinsho. Japanese journal of clinical medicine.

[A case of round atelectasis associated with spontaneous pneumothorax].

M. Munakata, Y. Kawakami, S. Ogura, 1992, Nihon Kyobu Shikkan Gakkai zasshi.

Multiple Endobronchial Schwannomas Arising at the Bronchial Spur of Two Different Sites

M. Nishimura, H. Dosaka-akita, S. Ogura, 2003 .

[Five cases of purple urine bag syndrome in a geriatric ward].

Y. Kawakami, S. Ogura, T. Ishida, 1999, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature review.

M. Nishimura, M. Munakata, H. Dosaka-akita, 2014, Molecular and clinical oncology.

[Flow cytometric detection of the rate of intracellular anthracycline-accumulation].

Y. Kawakami, S. Ogura, K. Yamazaki, 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.

M. Nishimura, S. Ogura, A. Ishizaka, 2003, American journal of respiratory and critical care medicine.

A phase II study of gefitinib as a first-line therapy for advanced non-small cell lung cancers with epidermal growth factor receptor (EGFR) gene mutations.

M. Nishimura, H. Dosaka-akita, S. Ogura, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[A case of bronchial actinomycosis associated with bronchoscopically removed broncholith].

Y. Kawakami, S. Ogura, H. Kunikane, 1992, Nihon Kyobu Shikkan Gakkai zasshi.

[A case of pulmonary sarcoidosis with calcification in the lung].

Y. Kawakami, S. Ogura, S. Abe, 1989, Nihon Kyobu Shikkan Gakkai zasshi.

Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.

M. Nishimura, H. Dosaka-akita, Y. Kawakami, 2002, Anticancer research.

Histopathologic consideration of fiducial gold markers inserted for real-time tumor-tracking radiotherapy against lung cancer.

Koichi Yamazaki, Hiroki Shirato, Yasuhiro Hida, 2008, International journal of radiation oncology, biology, physics.

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

M. Nishimura, H. Dosaka-akita, S. Ogura, 2006, British Journal of Cancer.

Long-term Monitoring and Analysis for Changing of Selectivity and Consumption of Antimicrobial Drugs Estimated with AUD in Our Hospital I

S. Ogura, Michiya Kobayashi, K. Tadano, 2009 .

Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas.

M. Nishimura, K. Furuuchi, T. Moriuchi, 2002, Cancer.